AI-generated price forecast for Abbott Laboratories (ABT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of October 2026: K3vl4r's AI model currently reads ABT as 3/4 bullish across its horizons (3 of 4 timeframes pointing up), with a last price of 97.51. See our public, auditable track record →
Last price
97.51
AI outlook
3/4 bullish
Timeframes up
3 / 4
| Horizon | Direction | Projected move (end of horizon) | Bullish prob. |
|---|---|---|---|
| 1-hour~4 weeks out | ▼ Down | -4.41% | — |
| 4-hour~2 months out | ▲ Up | +6.29% | — |
| Daily~3 months out | ▲ Up | +10.36% | 100% |
| Weekly~1.7 years out | ▲ Up | +20.32% | — |
Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.
| Member | Action | Date | Amount |
|---|---|---|---|
| Richard Dean Dr McCormick | ▼ Sell | 2026-07-30 | $1001–15000 |
| Mike Kelly (spouse) | ▼ Sell | 2026-07-17 | $1001–15000 |
| Richard W. Allen (spouse) | ▼ Sell | 2026-07-14 | $15001–50000 |
| Rick Larsen | ▼ Sell | 2026-07-08 | $1001–15000 |
| Gilbert Cisneros | ▲ Buy | 2026-06-16 | $1001–15000 |
23 disclosures in the last year. Track what Congress is trading across the whole market in the app — get started free.
From the market-news feed the forecasts are read against.
🔒
See the full ABT forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's AI model currently reads ABT as 3/4 bullish — 3 of 4 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects ABT toward $97.49 over the next ~4 weeks, a -0.0% move from $97.53. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Over its longest horizon (~~1.7 years), the model's projected target for ABT is $97.70 (+0.2% vs $97.50). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Healthcare forecasts — browse the full sector.
Or see the full ABT price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.